Head and Neck Cancer SPORE
Head and Neck Cancer SPORE
批准号:
9319632
负责人:
Robert L. Ferris
金额:
$229.39万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2020-06-30
关键词:
Adjuvant TherapyAntibodiesApplied ResearchAreaBasic ScienceBioinformaticsBiologyBiometryBiopsyBroccoli - dietaryCancer CenterCancer PatientCetuximabChemopreventionClinicalClinical ResearchClinical SciencesCollaborationsCommunitiesCytotoxic T-Lymphocyte-Associated Protein 4DetectionDevelopmentDiagnosisDiseaseFDA approvedFacultyFeedbackFine needle aspiration biopsyFundingGoalsHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and neck structureHealth Care CostsHistologyImmune signalingImmunotherapeutic agentImmunotherapyIncidenceIndividualIndolentInformaticsInstitutionInternationalMalignant NeoplasmsMalignant Squamous Cell NeoplasmMalignant neoplasm of thyroidMediatingMemorial Sloan-Kettering Cancer CenterMicrobubblesMolecularMolecular TargetMorbidity - disease rateNeck CancerNeoplasm MetastasisOhioOligonucleotidesOperative Surgical ProceduresOutcomePatient-Focused OutcomesPatientsPeriodicityPharmaceutical PreparationsPreparationPreventionPrimary NeoplasmProgram DevelopmentRecurrenceRegulatory T-LymphocyteResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResource InformaticsResourcesRiskRisk stratificationRoleSTAT3 geneSeedsSensitivity and SpecificitySpecialized Program of Research ExcellenceTestingTherapeuticTherapeutic EffectThyroid GlandThyroid NoduleTissuesTranslational ResearchTranslationsUltrasonographyUnited StatesUniversitiesUnnecessary SurgeryWorkaggressive therapyanticancer researchbasecancer therapycareer developmentimmune activationimprovedimproved outcomeindividual patientinhibitor/antagonistinterdisciplinary approachmortalitymultimodality cancer therapynext generation sequencingnovelnovel diagnosticsphase I trialpredictive markerpreventprognosticprogramspublic health relevancereceptorresearch and developmentresponsesequencing platformtargeted agenttreatment strategytumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The University of Pittsburgh proposes to continue a Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer. The overall goals of the Head and Neck SPORE are to improve the prevention and treatment of head and neck cancer as well as the detection and treatment of thyroid cancer (new in this renewal). The SPORE program consists of four translational research projects, 3 focused on head and neck squamous cell carcinoma (HNSCC) and one focused on thyroid cancer, two research cores, an administrative core, a developmental research program and a career development program. The SPORE will use an interdisciplinary approach to meet its objectives by carrying out projects jointly led by investigators in basic, applied and clinical science. The long-term goal of the Head
and Neck SPORE is to conduct clinical studies based on research results from the translational research projects that will serve as the basis for improving the outcome of individuals diagnosed with head and neck cancers. The four main projects include: (1) Chemoprevention of Head and Neck Cancer; (2) Optimization of STAT3 Decoy Delivery for Head and Neck Cancer Treatment; (3) Checkpoint Receptor Targeting to Enhance Cetuximab Efficacy Against HNSCC; and (4) Molecular-Guided Risk Stratification of Thyroid Nodules and Cancer. The three cores will interact closely to assist the main research projects, developmental research projects and career development investigators in carrying out translational head and neck cancer research. The research cores include: (a) Histology/Tissue and (b) Informatics, Biostatistics and Bioinformatics. The Administrative Core will solicit feedback from the Internal and External Scientific Advisory Boards and provide scientific, regulatory and fiscal oversight for the SPORE program. The Head and Neck SPORE investigators will work together to synergistically achieve the goals of the program and will also continue to interact closely with investigators from other Head and Neck and Thyroid SPOREs at other institutions, as well as the cooperative groups, to improve the outcome of patients with cancers of the head and neck.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs
-
批准号:10573334
-
项目类别:
-
资助金额:$68.14万
-
财政年份:2022
-
负责人:Robert L. Ferris
-
依托单位:
Mechanisms of PD-1 and Tim-3 crosstalk in tumor-infiltrating lymphocytes
-
批准号:9898328
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2016
-
负责人:Robert L. Ferris
-
依托单位:
Mechanisms of PD-1 and Tim-3 crosstalk in tumor-infiltrating lymphocytes
-
批准号:9250721
-
项目类别:
-
资助金额:$49.56万
-
财政年份:2016
-
负责人:Robert L. Ferris
-
依托单位:
Mechanisms of PD-1 and Tim-3 crosstalk in tumor-infiltrating lymphocytes
-
批准号:10745167
-
项目类别:
-
资助金额:$54.14万
-
财政年份:2016
-
负责人:Robert L. Ferris
-
依托单位:
Immune activation by cetuximab in head and neck cancer patients
-
批准号:8289554
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2010
-
负责人:Robert L. Ferris
-
依托单位:
Immune activation by cetuximab in head and neck cancer patients
-
批准号:8685765
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2010
-
负责人:Robert L. Ferris
-
依托单位:
Immune activation by cetuximab in head and neck cancer patients
-
批准号:8705630
-
项目类别:
-
资助金额:$17.81万
-
财政年份:2010
-
负责人:Robert L. Ferris
-
依托单位:
Immune activation by cetuximab in head and neck cancer patients
-
批准号:8096694
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2010
-
负责人:Robert L. Ferris
-
依托单位:
Immune activation by cetuximab in head and neck cancer patients
-
批准号:8499285
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2010
-
负责人:Robert L. Ferris
-
依托单位:
Chemokine Signals in Head and Neck Cancer Progression
-
批准号:7098453
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2006
-
负责人:Robert L. Ferris
-
依托单位:
Chemokine Signals in Head and Neck Cancer Progression
-
批准号:7569412
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2006
-
负责人:Robert L. Ferris
-
依托单位:
Chemokine Signals in Head and Neck Cancer Progression
-
批准号:7763909
-
项目类别:
-
资助金额:$25.47万
-
财政年份:2006
-
负责人:Robert L. Ferris
-
依托单位:
Chemokine Signals in Head and Neck Cancer Progression
-
批准号:7226238
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2006
-
负责人:Robert L. Ferris
-
依托单位:
Chemokine Signals in Head and Neck Cancer Progression
-
批准号:7355589
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2006
-
负责人:Robert L. Ferris
-
依托单位:
DIRECT MEASUREMENT RATES SYNTHESIS TURNOVER T-LYMPHOCYTES HEAD/NECK CANCER
-
批准号:7201095
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2005
-
负责人:Robert L. Ferris
-
依托单位:
Core A: Administrative Core
-
批准号:10331956
-
项目类别:
-
资助金额:$44.72万
-
财政年份:2004
-
负责人:Robert L. Ferris
-
依托单位:
Core A: Administrative Core
-
批准号:10704502
-
项目类别:
-
资助金额:$44.68万
-
财政年份:2004
-
负责人:Robert L. Ferris
-
依托单位:
Checkpoint Receptor Targeting to Enhance Cetuximab Efficacy Against HNSCC
-
批准号:9149604
-
项目类别:
-
资助金额:$15.39万
-
财政年份:2004
-
负责人:Robert L. Ferris
-
依托单位:
Administrative Core
-
批准号:9149601
-
项目类别:
-
资助金额:$16.11万
-
财政年份:2004
-
负责人:Robert L. Ferris
-
依托单位:
Specialized Program of Research Excellence
-
批准号:8707192
-
项目类别:
-
资助金额:$215.55万
-
财政年份:2004
-
负责人:Robert L. Ferris
-
依托单位:
海外基金